Steven Cohen's NVAX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.52 M shares of Novavax, Inc. (NVAX) worth $12.36 M, representing 0.02% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 1.5 M shares. Largest reduction occurred in Q4 2020, reducing 534,019 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.5 M | Add 9137.67% | 1.52 M | $8.14 |
| Q4 2025 | -80,482 | Reduce 83.04% | 16,435 | $6.72 |
| Q3 2025 | +96,917 | New Buy | 96,917 | $8.67 |
| Q3 2023 | -3,194 | Sold Out | 0 | $0.00 |
| Q2 2023 | +3,194 | New Buy | 3,194 | $7.43 |
| Q3 2022 | -500 | Sold Out | 0 | $0.00 |
| Q2 2022 | +500 | New Buy | 500 | $52.00 |
| Q2 2021 | -83,800 | Sold Out | 0 | $0.00 |
| Q1 2021 | +20,400 | Add 32.18% | 83,800 | $181.31 |
| Q4 2020 | -534,019 | Reduce 89.39% | 63,400 | $111.51 |
| Q3 2020 | +597,419 | New Buy | 597,419 | $108.35 |
Steven Cohen's Novavax Investment FAQs
Steven Cohen first purchased Novavax, Inc. (NVAX) in Q3 2020, acquiring 597,419 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Novavax, Inc. (NVAX) for 11 quarters since Q3 2020.
Steven Cohen's largest addition to Novavax, Inc. (NVAX) was in Q1 2026, adding 1,518,211 shares worth $12.36 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,518,211 shares of Novavax, Inc. (NVAX), valued at approximately $12.36 M.
As of the Q1 2026 filing, Novavax, Inc. (NVAX) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Novavax, Inc. (NVAX) was 1,518,211 shares, as reported at the end of Q1 2026.